Oncorus
Signal active
Organization
Contact Information
Overview
Oncorus, Inc. is a lean early-stage biotechnology company developing a next-generation immunotherapy platform to treat cancer. Oncorus was founded MPM Managing Director Mitch Finer, a well-known biotechnology entrepreneur. Oncorus is a leader in corporate philanthropy, and has taken a pledge to donate a portion of product sales to fund promising cancer research and to support cancer care in the developing world.
About
Industries
Biotechnology, Medical, Therapeutics, Oncology
Founded
2015
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Oncorus headquartered in United States, North America, operates in the Biotechnology, Medical, Therapeutics, Oncology sector. The company focuses on Biotechnology and has secured $17.5B in funding across 80 round(s). With a team of 51-100 employees, Oncorus is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Oncorus, raised $57.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
7
Lead Investors
0
Total Funding Amount
$218.5M
Details
3
Oncorus has raised a total of $218.5M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Early Stage Venture | 79.5M | ||
| 2016 | Early Stage Venture | 5.0M | ||
| 2016 | Early Stage Venture | 57.0M |
Investors
Oncorus is funded by 30 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Excelyrate Capital | - | FUNDING ROUND - Excelyrate Capital | 57.0M |
| Long March Investment Fund | - | FUNDING ROUND - Long March Investment Fund | 57.0M |
| Oncorus | - | FUNDING ROUND - Oncorus | 57.0M |
| SunStates Fund | - | FUNDING ROUND - SunStates Fund | 57.0M |
Recent Activity
There is no recent news or activity for this profile.